Phase
Condition
Allergies & Asthma
Allergy
Treatment
Placebo
Wheat flour
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
All the patients will meet the recently proposed criteria:
negative serum anti-tissue transglutaminase and antiendomysium (EmA) immunoglobulin (Ig)A and IgG antibodies
absence of intestinal villous atrophy
IgE-mediated immunoallergic tests negative to wheat (skin prick tests and/or serumspecific IgE detection)
follow-up duration >12 months after the initial diagnosis
at least two outpatient visits during the follow-up period.
Adjunctive criteria adopted in our patients will be:
resolution of the gastrointestinal symptoms on a standard elimination diet, withoutwheat, cow's milk, egg, tomato, chocolate, or other food(s) causing self-reportedsymptoms
symptom reappearance on DBPC wheat challenge, performed as described previously. Asin previous studies, DBPC cow's milk protein challenge and other "open" foodchallenges will be also performed.
Exclusion
Exclusion Criteria:
Exclusion criteria will be:
age <18 years
positive EmA in the culture medium of the duodenal biopsies, even if the villi tocrypts ratio in the duodenal mucosa was normal
self-exclusion of wheat from the diet and refusal to reintroduce it before enteringthe study
other organic gastrointestinal diseases (i.e. careful exclusion of Crohn's disease)
concomitant treatment with steroids and/or antihistamines.
Study Design
Study Description
Connect with a study center
Department of Internal Medicine, Giovanni Paolo II Hospital of Sciacca
Sciacca, Agrigento 92019
ItalyActive - Recruiting
Department of Internal Medicine, University Hospital of Palermo
Palermo, 90129
ItalyActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.